Nicola Alexander Hanania

11PUBLICATIONS
23CO-AUTHORS
Respiratory diseasesMajor global burdens of diseaseClinical chemistry (incl. diagnostics)PharmacogenomicsMulticultural, intercultural and cross-cultural studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 26, 2024
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences.

Mario Cazzola, Clive P Page, Nicola A Hanania

|Dec 15, 2023
Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection.

Christopher Wallick, Tu My To, Stephan Korom

|Mar 31, 2023
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA.

Nicola A Hanania, Scott H Bunner, Lindsay G S Bengtson

|Dec 16, 2021
Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team.

Alpesh N Amin, Sharon Cornelison, J Andrew Woods

|Jul 01, 2021
Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials.

Nicola A Hanania, Scott Caveney, Tedi Soule

|Oct 15, 2020
Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study.

Abebaw M Yohannes, Michelle N Eakin, Janet T Holbrook

Pageof 2

Frequent Collaborators

2 joint publications

Abebaw Mengistu Yohannes

2 joint publications

Muhammad Adrish

1 joint publications

Anna M Baker

1 joint publications

Lynn B Gerald